SEC Form 4 · accession 0001193125-26-359525
Pyxis Oncology, Inc. · PYXS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jakob Dupont
Director
Period of report
Aug 20, 2026
Accepted (ET)
Aug 20, 2026 · 6:18 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001782223
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $3.12 | Aug 20, 2026 | A | 46,000 | A | — | Aug 20, 2036 | Common Stock | 46,000 | 46,000 | D |
Explanation of responses
- F1The shares subject to this option will vest in equal monthly installments through October 31, 2026, subject to the reporting person's continued service through the applicable vesting date.